Merck cleared in personal injury case against Vioxx

doi:10.1136/bmj.331.7525.1101-a

BMJ 2005;331:1101 (12 November), doi:10.1136/bmj.331.7525.1101-a

News

Merck cleared in personal injury case against Vioxx

Susan Mayor

London

The first 150 words of the full text of this article appear below.

The pharmaceutical company Merck has won a personal injury courtcase associated with its cyclo-oxygenase-2 inhibitor rofecoxib(Vioxx) in the United States, a jury ruled in Atlantic Citylast week. This is the second case to be brought against thedrug giant out of more than 6000 claims expected from peopleor their relatives who say they were harmed by rofecoxib. Mercklost the first case.

In the most recent case, the state court jury found by an eightto one vote that Vioxx had not caused Frederick Humeston, a60 year old Idaho postal worker, to have a heart attack in September2001. The plaintiff had alleged that he had had a heart attackas a result of intermittent use of Vioxx over a two month period.

The jury also concluded unanimously that the company had properlymarketed Vioxx. It found that Merck had given doctors adequatewarning about . . . [Full text of this article]

-->
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to StumbleUpon StumbleUpon Add to Technorati Technorati What's this?